Investment Thesis
PAVmed has experienced a catastrophic operational collapse with revenue declining 97.6% YoY to just $71K, while the company burns $5.2M annually in operating cash. With only $1.5M cash remaining and a critical liquidity crisis (current ratio 0.17x), the company has approximately 3-4 months of runway at current burn rates.
Strengths
- Moderate debt-to-equity ratio of 0.23x indicates low financial leverage relative to equity base
- Maintains $34M in stockholders equity on balance sheet providing potential asset value
- Long-term debt of $7.8M is manageable relative to asset base
Risks
- Revenue collapsed 97.6% YoY to $71K, indicating fundamental business model failure
- Severe liquidity crisis with current ratio of 0.17x and insufficient cash to cover current liabilities
- Operating cash flow of -$5.2M annually with only $1.5M cash creates imminent solvency risk
- Negative gross margin of -253.5% indicates operations are unprofitable on sales
- Operating loss of $21.8M in latest period with negative operating margins exceeding -30,000%
- Extremely limited cash runway of approximately 3-4 months at current burn rate
Key Metrics to Watch
- Monthly cash burn rate and remaining liquidity runway
- Sequential quarterly revenue trend and stabilization indicators
- Working capital position and current ratio trajectory
Financial Metrics
Revenue
71.0K
Net Income
401.0K
EPS (Diluted)
$-5.63
Free Cash Flow
-5.2M
Total Assets
38.8M
Cash
1.5M
Profitability Ratios
Gross Margin
-253.5%
Operating Margin
-30,712.7%
Net Margin
564.8%
ROE
1.2%
ROA
1.0%
FCF Margin
-7,376.1%
Balance Sheet & Liquidity
Current Ratio
0.17x
Quick Ratio
0.17x
Debt/Equity
0.23x
Debt/Assets
42.5%
Interest Coverage
-838.69x
Long-term Debt
7.8M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-14T00:36:22.919887 |
Data as of: 2025-12-31 |
Powered by Claude AI